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EXPERIMENTALPROCEDURES

Preparation of Adipocytes and Cell Incubations-Adipocytes were
isolated by collagenase treatment according to themethod of Rodbell
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tion-inactivation (6). The CAMP-dependent protein kinase is
usually present in tissues as a mixture of type I and type I1
isozymes (7, 8). By several criteria, the rat adipose tissue
protein kinase appears to be primarily a type I1 isozyme but
it may not be identical with the type I1 kinase from rat cardiac
tissue (9) and it has not been determined which isozyme is
ultimately responsible for the lipolytic response.
It has been established that both type I and type I1 isozymes
are composed of two monomeric catalytic subunits and an
inhibitory, dimeric regulatory subunit containing two CAMPbinding sites per monomeric chain (10). These intrachain
CAMP-binding sites can be differentiated based on their
cAMP dissociation rates (11,12) andcAMP analog specificity
(12). Site 1 is characterized by a slower dissociation rate and
has arelative selectivity for cAMP analogs modified at the C8 position on the adenine ring (C-8 analogs) while Site 2 has
a faster dissociation rate and is more selective for analogs
modified at the C-6 position (C-6 analogs). [3H]cIMP (Site 2
selective) and 8-a~ido-[~~P]cAMP
(Site 1 selective) binding
experiments established that binding of cyclic nucleotides at
either site stimulatesbinding at the other sitefor both type I
and type I1 protein kinase isozymes (13, 14). Further, it was
demonstrated for both isozymes that a synergism of protein
kinase activation occurs using a combination of Site 1 and
Site 2 selective analogs (15). For Site l-selective analogs, a
nitrogen atom attached at C-8 is optimally synergistic with
C-6 analogs when using type I while a sulfur atom attachment
is most effective using type I1 (15).
In the present studies, we extend these in vitro findings to
demonstratea synergism of the CAMP-mediated lipolytic
response in isolated intact adipocytes. In addition, we expand
previous cyclic nucleotide structure-activity studies to correlate analog effects on protein kinase activation and lipolysis,
and explore the factors responsible for the lipolytic efficacy
of the analogs. By adding analog combinations tointact
tissues, novel approaches can be made to delineate cellular
cyclic nucleotide effector control mechanisms. First, a new
test
isavailable to establish whether or not the proteinkinase
The CAMP-dependentprotein kinase mediates most, if not
all, of the effects of cAMP in mammalian tissues (1, 2). Of is the mediator of a particular response. Second, the particular
present interest is the regulation of lipolysis in adipocytes via isozyme or isozyme mixture responsible for the effect in
the hormone-sensitive lipase. The only established mecha- tissues can potentially be identified. Third, because cyclic
nism of regulation of the lipase is CAMP-dependent phospho- nucleotide binding to Sites 1 and 2 is cooperative, an estimarylation-activation (3-5) and M$+-requiring dephosphoryla- tion can be made of the magnitude of the sensitivity magnification at the protein kinase step in the intact tissue. Last,
* This work was supported in part by Research Grant AM 15988 since analog combinations are synergistic, this allows for the
from the National Institutes of Health. The costs of publication of use of lower total analog concentration to obtain the same
this article were defrayed in part by the payment of page charges. cellular response as would be obtained using a single analog.

Twenty-five cyclic nucleotide analogs were tested
individually to act as lipolytic agents and to activate
adipocyte protein kinase. The lipolytic potency of individual analogs correlated better with their K , for
protein kinase and theirlipophilicity rather than with
either parameter alone. Some of the most potent lipolow
lytic analogs had high Iaovalues for the particulate
K , cAMP phosphodiesterase suggesting that their effect was not due to raising endogenous cAMP levels
through inhibition of phosphodiesterase. The most potent lipolytic analogs contained a thio moiety at the C8 or C-6 position. These analogs exhibited concave
upward dose-response curves. At high concentrations,
some analogs were as effective as optimal concentrations of epinephrine in stimulating
glycerol release.
The regulatory subunit of protein kinase has two
different intrachain CAMP-binding sites and cAMP
analogs modified at theC-8 position (C-8 analogs) are
generally selective for Site 1 and analogs modified at
the C-6 position (C-6 analogs) are generally selective
for Site 2(Rannels, S . R., and Corbin, J. D. (1980) J.
Biol. Chem. 255,7085-7088). Thus, C-8 and C-6 analogs were tested in combination to stimulate lipolysis
in intact adipocytes and to activate protein kinase in
vitro. Each process was stimulated synergistically by
a combination of a C-6 and C-8 analog. Two C-8 analogs or two C-6 analogs added together did not cause
synergism of either process. For both lipolysis and
protein kinase activation,C-8 thio analogs acted more
synergistically than C-8 amino analogs when incubated in combination with C-6 analogs, a characteristic
of type I1 protein kinase. It is concluded that the observed synergism of lipolysis is due to binding of cAMP
is the type
analogs to both intrachain sites and that it
I1 protein kinase isozyme which is responsible for the
lipolytic response.
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pellet was washed by gentle resuspension in 5 ml of TSE buffer
followed by centrifugation. The resulting pellet was resuspended in
5-10 ml of 10 mM Tris-HCI, 1 mM EDTA (pH 7.5) using 10 strokes
of the pestle and centrifuged at 20,000 rpm, and the supernatant
fraction was assayed for low K , phosphodiesterase activity.
cyclic nucleotide phosphodiesterase activity was measured as described by Loten et al. (19). In all experiments, enzyme was added in
a concentration which resulted in the hydrolysis of approximately
25% of the substrate. [SH]cAMPwas always present at a concentration of 0.1p M and cyclic nucleotide analogs were added to the reaction
in a wide range of concentrations. Their ability to compete for
CAMPhydrolysis is expressed as the concentration of analog which
inhibited cAMP hydrolysis by 50% (Iw).
Isolation of CAMP-dependentProtein Kinase-The CAMP-dependent protein kinase was partially purified from adipocytes using
DEAE-cellulose according to the method of Corbin et al. (9). Adipocytes were prepared as described above. After two washes with KRBA,
adipocytes were washed twice with 10 mM potassium phosphate, 1
mM EDTA, and 250 mM sucrose (pH 6.8) (buffer A) and suspended
in the same buffer except with 10 mM EDTA (buffer B). The adipocytes were hand-homogenized with 20 strokes of the B pestle using a
Dounce homogenizer.The homogenate was centrifuged for 30 min at
20,000 X g. One main peak of protein kinase activity eluted from
DEAE-cellulose a t 170 mM NaCl as previously shown for adipose
tissue (8).
Materials-Bovine serum albumin was purchased from Reheis
Chemical Co. Collagenase wasobtained from Worthington Diagnostic
Systems, Inc. Glycerol kinase, glycerol-3-phosphate dehydrogenase
and N6-phenylisopropyladenosinewere products of Boehringer Mannheim. 2'-5'-Dideoxyadenosine was obtained from P-L Biochemicals,
Inc. 8-Thioisopropyl-CAMPand 8-thiobenzyl-CAMPwerereceived
from ICN. 8-Aminobutylamino-CAMPwas synthesized as previously
described (14). The following analogs were generously provided by
Drs. Jon Miller and Robert Suva of the Biomedical Research Laboratory, Life Sciences Division, SRI International, Menlo Park, C A
N6-carbamoylpropyl-CAMP, 6-thiomethyl-cNMP,
M-hydroxyCAMP, 8-thio-pNOzbenzyl-cAMP,
8-hydroxy-cAMP,
8-aminoethanol-CAMP, 2-trifluoromethyl-cAMP, and 2-aminodimethylCAMP. All other cyclic nucleotide analogs were purchased from
Sigma.
RESULTS

Effect of Cyclic Nucleotide Analog Concentration on Glycerol
Release-A variety ofcyclic nucleotide analogs at various
concentration were tested for their lipolytic effects on adipocytes. Adipocyte incubations with analogs or hormones were
carried out at 20 "C.When experiments were done at 37 "C,
similar dose-response or time-response characteristics were
seen except the time-response curves were shifted to theleft.
Fig. 1 shows the dose-response curves of 16 representative
analogs. The studies in Fig. 1 and Table I were carried out by
measuring glycerol release after 60 min of incubation with
each individual analog at several concentrations. Duplicate
glycerol determinations were done on each of two or more
adipocyte preparations. Generally, the various analogs fit into
three major catagories based on their dose-response characteristics. The effects of N6-benzoyl- and 8-bromo-CAMPwere
relatively linear with concentration (Fig. IC). Analogs which
were modified with alkyl chains at the C-6 positions (N6-Bt
and N6-AHCM, Fig. 1, D and B, respectively), a hydroxyl at
the C-6 or C-8 position (N6-hydroxy- and 8-hydroxy-CAMP,
Fig. 1B)or amine-containing substituents at theC-8 position
(8-aminomethyl- and 8-aminobenzyl-cAMP, Fig. 1A)had hyperbolic dose-response curves. Concave-upward dose-response curves were characteristic for analogs containing a
thio derivative (8-thiomethyl-CAMP, 8-thiobenzyl-cAMP,
Fig. 1A and 6-thiomethyl-cNMP, Fig. 1B).
Table I shows values for glycerol release of 23 cyclic nucleotide analogs tested as lipolytic agents. The analogs are
listed according to decreasing efficacy for a modification of a
The abbreviations used are: KRBA, Krebs-Ringer bicarbonate given position on the adenine ring. The values for glycerol
buffer; IBMX, 3-isobutyl-1-methylxanthine;
EGTA, ethylene glycol- release (nanomoles/g/pM analog/h) were determined from
linear regressions of dose-response curves from experiments
bis(p-aminoethyl ether)-N,N,N',N'-tetraacetic acid.
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(161, from epididymal fat pads of130-200-g Sprague-Dawley rats.
Epididymal fat was incubated in KRBA' containing 1 mMCaC12,
3.5% bovine serum albumin (fraction V). The cells were washed and
suspended in thesame buffer such that the fatdry weight was 35-55
mg/ml cell suspension. Incubations were carried out in closed polypropylene vials, gassed with 95% 0 2 and 5% COa in the presence or
absence of various concentrations of cyclic nucleotide analogs or
other lipolytic agents. When IBMX was present, the concentration
.
were routinely done in a shaking water bath
was 200 p ~Incubations
(64 cycles/min) at 20 "C. The synergism of lipolysis was quantitated
using a synergism quotient which is defined as the ratio of the
observed level of glycerol release when C-6 and C-8 analogs are
incubated in combination to the expected level of glycerol release
determined from the sum of the effects of each individual analog.
Glycerol Determination-At various times, aliquots of incubation
mixture were made 3% perchloric acid and then 13% (v/v) carbon
tetrachloride. The samples were mixed and spun ina desk-top clinical
centrifuge for 5-10 min. After KOH neutralization, aliquots of the
supernatants were removedand assayed for glycerol according to the
method of Wieland (17). Lipolysis is expressed as micromoles of
glycerol/g of fat. The fat dry weightwas determined by spotting
aliquots of incubation mixtures on nitrocellulose papers, drying, and
weighing.
Determination of Partition Coefficients-The partition coefficients
of various cyclic nucleotide analogs were determined using 1-butanol
as theorganic phase and 0.05 M potassium phosphate (pH 7.4) as the
aqueous phase. The two phases were first mixed and allowed to
separate overnight, and the resulting phases were used to determine
the partition coefficients. 3 ml of 1-butanol were added to 1 ml of
cyclic nucleotide analog (50 p M ) diluted in 0.05 M potassium phosphateand vigorously mixed for 30 s on a Vortex-Genie (Fisher
Scientific) at a setting of 4. The samples were spun in a desk-top
clinical centrifuge to speed the phase separation. The absorbance of
the analog in potassium phosphate was determined at 260 nm before
and after 1-butanol extraction. The difference in absorbance was
taken asthat fraction of analog which partitioned into the1-butanol.
The partition coefficient was determined by the ratio of the concentration of analog in the 1-butanol to the concentration in potassium
phosphate after organic extraction. The analogs partitioned less
effectively into tert-amyl alcohol but followed the same rank order as
with 1-butanol.
Protein Kinase Assay-The activity of the CAMP-dependent protein kinase was determined using a modification of the filter paper
assay procedure described by Roskoski (181, using the synthetic
as substrate. The reheptapeptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly)
action mixture contained 50 mM Tris (pH 7.5), 2% glycerol, 1 mM
EGTA, 43 mM 2-mercaptoethanol, 65 PM synthetic peptide, 200 PM
[Y-~*P]ATP
(100-200 cpm/pmol), 10 mMMgC12 in the presence or
absence of 5 IM CAMP.When IBMX was present, the concentration
. reaction was terminated after 5 min of incubation
was 200 p ~ The
at 30 "C.The reaction was linear inthe presence or absence of cAMP
for a t least 10 min. The CAMP-dependent protein kinase activity
ratio is defined as the ratio of activity measured in the absence and
I CAMP.
presence of 5 M
K. Determination for Cyclic Nwleotides-The K, for cAMP and
cyclic nucleotide analogs was determined in the standard protein
kinase assay in the presence of 200 PM IBMX. The data were fitted
to the Hill equation after subtraction of basal activity ratios which
were between 0.02 and 0.13. The cyclic nucleotide concentrations
were varied between 3 and 10,000 nM. Protein kinase was present at
0.5-1.0 nM regulatory subunit monomer for the DEAE-cellulose concentrated enzyme or 0.05-0.1 nM after separation by sucrose density
gradient centrifugation. The K, for cAMP was unaffected by pH
values between 6.8 and 8.0 or the presence or absence of sucrose
(2.5%), glycerol (2%), or IBMX (200 pM).
Preparation of Adipocyte Particulate Phosphodiesterase-The low
K,,, phosphodiesterase was prepared by modification of the method of
Loten et al. (19). Adipocytes from four rat epididymal fat pads were
prepared as described above. Cells were washed two times with KRBA
and three additional times with 10 mM Tris-HCI, 1 mM EDTA (pH
7.5) containing 250 mM sucrose (TSE buffer). Cells were resuspended
in 5 ml of TSE buffer and homogenized with 10 strokes of the A
pestle using a Dounce homogenizer. The homogenate was centrifuged
for 30 min at 20,000 rpm and the supernatant was discarded. The
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TABLE
I
Effect of cyclic nucleotides on glycerol release
Cyclic nucleotide analogs are listed in order from the most to the least potent for a given modification on the
purine ring. The average analog concentration effect was determined from linear regression analysis of doseresponse curves like those indicated in Fig. 2. Glycerol release was determined as described under "Experimental
Procedures" and is expressed as nanomoles of glycerol/g of fat, dry weight/pM of analog/h.
Cyclic nucleotide analog
Abbreviated name

C-6 analog

C-8 analog

C-2 analog
cGMP analog

cAMP
Ne-Carbamoylpropyl
Ne-Benzoyl
6-Thiomethyl nebularine
N'-Hydroxy
Ne-Butyryl
Ne-Aminohexylcarbamoylmethyl
cIMP
8-Thio-pNOzbenzyl
8-Thiomethyl
8-Thioisopropyl
8-Thiobenzyl
8-Hydroxy
8-Amino
8-Bromo
8-Amiiohexylamino
8-Aminomethyl
8-Aminobenzyl
8-Aminoethanol
2-Trifluoromethyl
2-Aminodimethyl
8-Bromo
cGMP

Substituent

Glycerol release

-.

NB-CONH-C&i,
NB-CO*-C&
6-S-CHa-cNMP
NB-OH
P-COz-CaH,
N'-(CHZ)e-NH-CONH-CHS
8-S-pNOz-CHz-C&,
8-S-CHs
8-S-isoCaH,
8-S-CHZ-C&is
8-OH
8-NH2
8-Br
S-NH-(CHz)e-NHz
8-NH-CHa
8-NH-CHZ-Ca
8-NH-CH&-OH
2-CFs
2-N-(CH&
8-Br-cGMP

nmnf/duM/h
.
0.23
7.86
7.54
4.07
2.66
0.93
0.83
0.01
5.71
5.68
4.73
4.39
2.04
1.63
1.07
1.05
0.43
0.25
0.16
0.0
0.0
0.0
0.11
r
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z o y l - c were
~ ~ ~the most effective lipolytic agents tested.
Analogs modifiedwith a thiomoiety at theC-6 or C-8 position
were also very potent. On the other hand,analogs containing
amino derivatives at the C-8 position were relatively poor at
stimulating lipolysis. cIMP,cGMP, 8-bromo-cGMP, 2-trifluoromethyl-CAMP,2-aminodimethyl-CAMP, and CAMP itself were poor lipolytic agents. When analogs were ordered
based on their effects at lower concentrations (90 pM), a
2.0
similar order of efficacy wasobtained except N'-hydroxy- and
1.0
8-hydroxy-CAMPwere the most potent and 8-thiomethyl-,8thioisopropyl-, and 8-thiobenzyl-CAMPhad asomewhat lower
0 2 0 0 400 600 800 1000
rank. However, C-8 analogs with thio modifications were
always better lipolytic agents than analogs containing amino
substituents.
Several factors were considered to be responsible for the
efficacy of the analogs tested in these studies. An analog
should be an effective lipolytic agent if it 1) hasa good
lipophilic character so that it can pass through the plasma
membrane and enter the cell, 2) is an effective activator of
CAMP-dependent protein kinase which subsequently phosphorylates and activatesthe hormone-sensitive lipase, and 3)
is not hydrolyzed by the phosphodiesterases present in the
cell. Therefore, we attempted to measure parameters of the
2.0
1.0
analogs which would bepredictive of their ability to stimulate
glycerol release. As a measure of lipophilicity, the partition
0 200 400 600 800 l o o 0
coefficients of several analogs were determined. Several anaCyclic Nucleotide Concentration ()AM)
FIG. 1. The effect of cyclic nucleotide analog concentration logs were also tested for their ability to activate the type I1
on lipolysis. Lipolysis was determined by measuring glycerol release CAMP-dependent protein kinase. Since few of these analogs
after 1 h of incubation at 20 "C. The plotted values have been were available with radioactive labels, it was difficult to dicorrected for glycerol released in the absence of added cyclic nucleo- rectly study the hydrolysis of these derivatives. Alternatively,
tide analogs. N6-Bt,N6-butyryl; N6-AHCM, N6-aminohexylcarba- we studied the ability of some analogs to inhibit [3H]cAMP
moylpropyl.
hydrolysis by the low K,,, phosphodiesterase isolated from the
like those shown in Fig. 1. Since most of the analogs had adipocyte high speed pellet. Table I1 shows the values for
nonlinear dose-response characteristics, the order of Table I glycerol release taken from Table I with the partition coeffirepresents an average concentration effect. It follows that the cient, K, for protein kinase activation and the I, for the low
order was mainly determined by the highest concentration of K,,, CAMP-phosphodiesterase.
analog tested (910 p ~ ) N6-Carbamoylpropyl.
and N6-benAnalogs with hydrophobic substituents such as alkyl and
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TABLE
I1
Variousparameters of CAMPanalogs
Values for glycerol release were taken from Table I. The partition coefficient, K,, for protein kinase activation
and theIm for the low K , phosphodiesterase were determined as described under "Experimental Procedures."
~~

Glycerol
release

Protein kinase
activation

Partition
coefficient

nm&?/&M

anulogjh

7.9
7.5
5.7
4.7
4.4
1.6
1.1
0.9
0.4
0.3
0.2
0.0
0.0

46

aryl groups had high partition coefficients while analogs with
more hydrophilic substituents such as 8-amino derivatives,
cIMP, and cAMP had low partition coefficients. There was
no clear correlation between the partition coefficient of the
analog and its ability to stimulate glycerol release. Likewise,
there was no clear correlation between the K , of the analog
for protein kinase activation and its ability to serve as an
effective lipolytic agent. In addition, there appeared to be no
correlation between the lipolytic effectiveness of an analog
and its ability to inhibit the low K,,, phosphodiesterase as
indicated by 150values. The I60values in TableI1 indicate that
good lipolytic analogs required high concentrations to inhibit
[3H]cAMPhydrolysis. When the partition coefficient, the K,
for protein kinase activation, and the Im for the phosphodiesterase were all considered, the lipolytic effectiveness of the
analogs was explained (Table 11).
Comparison of Effectsof Epinephrine and Cyclic AMP Analogs on Lipolysis-Fig. 2 shows the effect of time on epinephrine and cAMP analog-stimulated glycerol release. Because
linear regression was used to determine the rates of glycerol
release when possible, all of the lines do not necessarily pass
through 0. Fig. 2 shows that 10 PM epinephrine in thepresence
of200 )LMIBMX resulted in a linear rate of 127 nmol of
glycerol/g of fat/min for at least 90 min. When IBMX was
deleted from the incubation media, the rate of lipolysis was
decreased by approximately 15-20%. The presence of high
concentrations of N'-benzoyl-cAMP (455 pM) and 8-bromocAMP (1364 PM)did not alterthe rate of epinephrine-induced
lipolysis. When 455 p~ N6-benzoyl- and 1364 p~ 8-bromocAMPwere incubated with adipocytes in the absence of
hormone, a concave-upward time course was seen. The rate
of lipolysis was 75 nmol of glycerol/g of fat/min in the first
30 min of incubation in this experiment but 130nmol of
glycerol/g of fat/min in last 30 min. When the concentrations
of N6-benzoyl- and 8-bromo-CAMPwere reduced (136 and
455 PM, respectively) and the incubation time was extended,
a more pronounced concave-upward time course was evident.
Millimolar concentrations of N6-benzoyl-, Ebthiomethyl-,
8-thiobenzyl-, 8-thio-pN02benzyl-, andN6-carbamoylpropylcAMP stimulated lipolysis at rates approximately equal to
epinephrine (not shown). Concave-upward time courses were
generally seen with all analogs which were effective lipolytic
agents. Since the concave-upwardtime-effect relationship was
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4.9
3.0
1.6
6.6
19.4
0.4
1.6
1.3
0.9
10.9
0.6
4.6
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PM

1.9
2.1
0.3
0.5
0.6
0.2
0.2
3.0
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FIG. 2. The effect of epinephrine and CAMP analogs on
lipolysis. Adipocytes were incubated in the presence of 10 p~ epinephrine alone (O), 10 phi epinephrine, and 200 phi IBMX (m), 10
pM epinephrine with 455 pM p-benzoyl- and 1364 pM 8-bromo455 phi W-benzoyl- and 1364 NM 8-bromo-CAMP (A),
cAMP (e),
and 136 SM N'-benzoyl- and 455 p~ 8-bromo-CAMP (V).Glycerol
release was determined as a measure of lipolysis at the indicated
times.

still seen when the adipocytes were preincubated for 60 min
before the addition of the analogs, it appears that theconcaveupward time courses were not due to the generation of cyclic
nucleotide-independent factor(s) during the experiment (data
not shown). The shape of these concave-upwardtime courses
was unaffected by adenosine (100 p ~ )phenylisopropyladen,
osine (0.1 and 10 p ~ ) 2',5'-dideoxyadenosine
,
(50 p ~ ) or
,
IBMX (200 p ~ )suggesting
,
that theadenosine receptors are
not sites of action of analogs or other factors generated during
the incubation which account for the concave-upward time
courses(20, 21). Since IBMX antagonizes the inhibitory
adenosine receptor of the adipocyte (22) as well as inhlbks
the phosphodiesterase, these data also suggest that under
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Cyclic AMP analog
NO-Carbamoylpropyl
Ns-Benzoyl
8-Thiomethyl
8-Thioisopropyl
8-Thiobenzyl
%Amino
8-Bromo
N6-Butyryl
8-Aminomethyl
8-Aminobenzyl
cAMP
2-Trifluoromethyl
cIMP

Phosphodiesterase

Synergism of CAMP Analogs

any given time point were considered. At intermediate concentrations of this analog pair, synergism quotients varied
from less than or equal to 1.0 after shortperiods of incubation
(15-30 min) to values of around 2.0 after longer incubation
periods (Fig. 3B). At higher concentrations of analog and
particularly after longer periods of incubation, synergism
quotients were higher (Fig. 3, C and D).When time-effect
relationships were linear, synergism quotients were calculated
using linear regression analysis. The synergism quotients were
1.35 and 2.0 in Fig. 3, A and B, respectively. However, when
time-effect relationships were not linear (Fig. 3, C and D),
calculation of the synergism quotient based on absolute net
glycerol values at any given point of determination may give
conservative estimations of the magnitude of synergism. Since
under these conditions the rate of lipolysis was changing, it
may be appropriate to consider the relative rates of glycerol
release between time points. In Fig. 3C, the rate of lipolysis
with each analog alone was linear while the rate of lipolysis
when both analogs were present was concave upward. The
synergism quotients calculated after 60 and 90 min of incubation were 1.2 and 1.8, respectively.If, however, the relative
rates between 30 and 60 min or 60 and 120 min were considered, the synergism quotients were 1.8 and 3.3, respectively.
However, the apparent disparity between the values calculated by these two approaches was reduced as the rate of
lipolysis due to a single analog varied with time as occurred
with higher concentrations of N'-benzoyl-CAMP (Fig. 3 0 ) .
Another approach to investigating the effects of cAMP
analog combinations on lipolysis was to keep one analog at a
constant concentration while the concentration of the other
analog was varied. Fig. 4 shows one experiment of this type
in which the Site 2-selective analog N'-benzoyl-cAMP and
the Site 1-selective analog 8-thioisopropyl-CAMPwere incubated alone and in combination. In Fig. 4 A , glycerol release
was measured after adipocytes were incubated for 2 h with 10

FIG. 3. The effect of increasing
concentrations of a fixed ratio of
P-benzoyl- and 8-bromo-CAMP on
synergism of lipolysis. N6-Benzoyl(0)and 8-bromo-CAMP (A) were incubated alone and in combination (0)at a
fixed ratio of about 3. Each part represents a different adipocyte preparation.
The values at each time point represent
glycerol determinations on duplicate incubations. Lipolysis was measured by
glycerol release.

T i m e ( Minutes)
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these conditions these processes play only a minor role in
analog-stimualted lipolysis.
Effect of Analog Combinations on GlycerolRelease-Previous studies from this laboratory have demonstrated that
binding of a CAMPanalog selective for either intrachain site
on the regulatory subunit of protein kinase stimulated binding
of a cAMP analog selective for the other site (13, 14). A
continuation of these studies demonstrated that two such
site-selective analogs could also be used in combination to
synergistically activate protein kinase (15). The main approach of the present studies was to determine if these in
uitro findings could be extended to isolated, intact cell preparations to demonstrate a synergism of a metabolic response
believed to be mediated by protein kinase. Consequently,
isolated adipocytes were incubated in the presence of siteselective cAMP analogs alone and incombination and glycerol
release was determined as a measure of lipolysis. The first
series of experiments of this type were carried out with the
Site 1-selectiveanalog 8-bromo-CAMPand the Site2-selective
analog N'-benzoyl-CAMP. The first approach was to carry
out time courses with increasing concentrations of a fixed
ratio of these analogs (Fig. 3). The basal, unstimulated rate
of glycerol release varied in this series of experiments from
essentially 0 (Fig. 3A) to 9 nmol/g of fat/min (Fig. 3B). This
control level of lipolysis was always subtracted from the
experimental values to obtain a net value for glycerol release.
To quantitate the resulting effects on glycerolrelease, a
synergism quotient was used. The synergism quotient was
defined as thenet effect of the analog combination on lipolysis
divided by the sum of the net individual analog effects on
lipolysis. A quotient greater than 1 indicated a synergistic
effect while a quotient less than 1 indicated that aninhibitory
effect on lipolysis occurred. For experiments using N'-benzoyl-CAMP and 8-bromo-CAMP,the synergism quotients were
generally not higher than 2.5 when the absolute net values at
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FIG. 4. Synergistic effect of W-benzoyl- and 8-thioisopropyl-CAMPon lipolysis. N'-Benzoyl-CAMP
(10phi) and 8-thioisopropyl-CAMP(100 p ~ were
)
incubated alone and inthe presence of various concentrations
of the other analog and glycerol release was determined after 2 h of incubation. The striped portion of the bars
represent glycerol values for 10 FM Ng-benzoyl-CAMP(A) and 100 pM 8-thioisopropyl-CAMP( B ) when incubated
alone. The open portion of the bars represent glycerol values for increasing concentrations of b-thioisopropylof the bars on the kft of each pair
cAMP ( A ) and N'-benzoyl-cAMP ( B ) when incubated alone. The height
represents thesum of the individual analog effects
or the expected glycerol value
if analogs were incubated together.
The total height of the solid bar indicates the observed glycerolvalue when analogs were incubated in combination
of the paired bars reflects the magnitude of
at the indicated concentrations. The differences between the heights
synergism of lipolysis. The data represent means and standard oferrors
triplicate determinations in
a representative
experiment. The insets show the synergism quotientat each concentration of analog combination. The synergism
quotient is defined under "Experimental Procedures."
W B Z L ,N'-benzoyl-CAMP; d-S-isoP, 8-thioisopropyl-CAMP.
p~ N6-benzoyl-CAMPand various concentrations of 8-thioisopropyl-CAMP and Fig. 5B shows the reverse approach in
which 100p~ 8-thioisopropyl-CAMPwas combined with various concentrations of N'-benzoyl-cAMP. The bar on the left
of each pair indicates the sum of the analog effects on lipolysis
while the bar on the right of each pair indicates the observed
lipolytic effects of the analog when combined in the incubation media. The insets show the synergism quotients which
were based on the ratios of the heights of these bars. 10 p~
N'-benzoyl-cAMP and 100 p~ 8-thioisopropyl-CAMP were
approximately equipotent as lipolytic agents (striped bars,
Fig. 4, A and B, respectively). When N6-benzoyl-CAMP(10100 p ~ and
) 8-thioisopropyl-CAMP (30-300 p ~ were
)
incubated alone, linear dose-response data were seen (open bars,
Fig. 4). At higher concentrations (1000 p ~ ) 8-thioisopropyl,
CAMP, unlike N'-benzoyl, demonstrated concave-upward
dose-response characteristics typical of the 8-thio-CAMPanalogs (Fig. 1).
When 10 p~ N'-benzoyl-cAMP was incubated with concentrations of 8-thioisopropyl-CAMP which alone were in a
region of linear dose-response effects (30, 100, and 300 pM),
a relatively constant degree of synergism was seen (Fig. 4A,
inset). The apparent maximum synergism quotient of about
1.5 was not increased when a lower (10 p ~ or) higher (1000
p ~ concentration
)
of 8-thioisopropyl-CAMPwas incubated in
combination with N'-benzoyl-cAMP. It is not surprising that
synergism was not seen at the highest concentration of 8thioisopropyl-CAMP tested since this analog concentration
alone elicited a maximal lipolytic response. The magnitude of
synergism seenwith this experimentalapproach was not
dependenton the concentration of 8-thioisopropyl-CAMP.
However, when 8-thioisopropyl-CAMPwas kept constant and

the concentration of N6-benzoyl-CAMP was varied, the synergism quotient was directly proportional to theconcentration
of N'-benzoyl-cAMP (Fig. 4B, inset). In these experiments,
the synergism quotient varied between 1.1 and 2.4 as the
concentration of N6-benzoyl-CAMPwas increased from 3 to
100 p ~ As
. the concentration of N6-benzoyl-CAMPwas increased to yield a maximal lipolytic effect, the synergism
quotient again approached 1.0 (data notshown). N6-BenzoylcAMP also had a dose-dependent synergistic effect on epinephrine-stimulated (3,25, and 200 nM) and IBMX (200 p ~ )
stimulated lipolysis (data notshown). At very low concentrations of N'-benzoyl-cAMP (1 p ~ ) an
, inhibition of 8-thioisopropyl-CAMP-stimulatedlipolysis was seen (synergism quotient = 0.65). When detailed time courses (such as those in
Fig. 3) were carried out, synergism quotients of less than 1
were sometimes seen. When this inhibition of glycerol release
was present, it was seen when at least one analog was present
at low concentrations and/or at early time points when the
concentration of the analog at its active site(s) wouldbe
expected to be low. N'-Benzoyl-cAMP, the most thoroughly
studied analog, frequently showed this characteristic.
Experiments similar to those in Fig. 4 carried out with N6benzoyl-CAMPand the Site
1-selectiveanalog 8-bromo-CAMP
produced similar results. A relatively constant synergism quotient of about 2.0 was seen when incubations were carried out
when the concentration of 8-Br-CAMP was varied in the
presence of a constant concentration of N'-benzoyl-cAMP
between 15 and 90 p~ 8-bromo-CAMP. An increasing magnitude of synergism was obtained when the concentration of
N'-benzoyl-cAMP was increased from 10 to 140 p~ in the
presence of 30 p~ 8-bromo-CAMP.
Synergism of lipolysis with cAMP analog combinations was
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TABLE
111
Lack of synergism of glycerol release with pairs of C-6 or pairs
Of C-8 analogs

T

Analog combination

Combination divided
by s u m of individual
effecta (synergism

quotient)

N6-Carbamoylpropyl (91 p ~ +)N6-benzoyl
(45 PM)
N6-Carbamoylpropyl (91 p M ) + N6-butyryl
(91 I ~ M )
W-Benzoyl(45 p M ) + N6-butyryl (91 p M )
8-Thiobenzyl (91 phf) + 8-aminomethyl (91 cM)
8-Thiobenzyl (91 @M) + 8-methyl (91 pM)
8-Aminomethyl (91 p M ) + 8-methyl (91p M )
8-Thiobenzyl (91 p M ) + 8-bromo (91 p M )
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FIG. 5. Comparison of synergism of lipolysis and synergism
of adipocyte type TI protein kinase activation using C-6 and
C-8 cAMP analogs. A, synergism of lipolysis was determined by
incubating adipocytes with C-6 analogs and C-8 analogs alone and in
combination and measuring glycerol released after 2 h of incubation.
The striped bars show the effects of N6-benzoyl-CAMP(left)and Necarbamoylpropyl-CAMP(right)when incubated alone. The unshoded
bars on the left of each pair of bars show the effects of the indicated
C-8 analog when incubated alone. The total height of the bar on the
right of each pair indicates the effects on glycerol release when the
indicated C-8 analogs were incubated with adipocytes in the presence
of N'-benzoyl-cAMP (left)or N6-carbamoylpropyl-CAMP(right).The
shaded portion of the bar indicates the extent of synergism. The data
represent the means and standard errors of four to eight determinations on each of two different adipocyte preparations. B, synergism
of protein kinase activation was determined by incubating adipocyte
type I1 protein kinase with C-6 analogs and C-8 analogs alone and in
combination in the standardprotein kinase assay. The activity ratios
represent the increases above basal due to the indicated concentrations of the various analogs. The basal activity ratio determined in
the absence and the presence of 5 p~ cAMP was 0.09. The protein
kinase was isolated by DEAE-cellulose chromatography. The data
indicate the means and standard errors of three or four determinations. N'BZL, N'-benzoyl-cAMP; Ne-CONH-P, N6-carbamoylpropyl-CAMP; 8-AHA, 8-aminohexylamino-CAMP8-ABA, 8-aminobutylamino-CAMP; 8-S-is0CJI,, 8-thioisopropyl-CAMP; 8-S-CH3, 8thiomethyl-CAMP.

seen when the sum of the lipolytic effects of the individual
analogs was between 10 and 50% of the optimally stimulated
level of glycerol release as determined by 10 ~ L epinephrine
M
in the presence of 200 W M IBMX. Synergism of lipolysis was
only seen when a Site 1-selective analog was incubated with
a Site 2-selective analog but not when two Site 1-selective or
two Site 2-selective analogs were combined(Table 111). When
two C-6 analogs or two C-8 analogs were combined such that

0.86
0.94
0.98
1.02
0.72
1.04

alone they stimulated lipolysis 10-20% each, their synergism
quotients were less than or equal to 1.
This laboratory had previously shown that bovine heart
type I1 and rat heart
type I protein kinase exhibited a different
C-8 analog specificity for stimulation of binding and synergism of activation when incubated with a C-6 analog (14,151.
Specifically,whenused in combination with C-6 analogs,
those analogs with a sulfur atom attached to C-8 acted more
synergistically using type 11 protein kinase and type I exhibited greater synergism using analogs with a nitrogen atom
attached at C-8. Consequently, the use of 8-thio- and 8-aminocAMP analogs in combination with C-6 analogs couldpotentially differentiate between a type I1 and a type I protein
kinase-mediated metabolic response. When adipocyte protein
kinase was isolated on DEAE-cellulose, it eluted at a salt
concentration consistent with a type I1 protein kinase. It was
therefore of interest to see if the site-specific analog pattern
of synergism of lipolysis could be correlated with synergism
of adipocyte type I1 protein kinase. Fig. 5A shows the lipolytic
effects of individual analogs and the sum of their effects such
that they can be compared with the effects of various analog
combinations. In Fig. 5A, the total height of the bar on the
right of each pair indicates the amount of glycerol released
when the adipocytes are incubated with the analog combinations. The shaded portion of the bars indicates the extent of
synergism. The observedlevels of glycerolreleasevaried
among the combinations depending on whether the C-6 analog
was incubated with a C-8-thio analog or a C-8-amino analog.
Incubation of N6-carbamoylpropyl-CAMPor N6-benzoylCAMPwith either 8-thio-CAMP analog produced
the greatest
degree of glycerol release over that expected from the sum of
the individual analogs alone (synergism quotients = 2.5-3.6).
Both of the C-6 analogs acted far more synergistically when
incubated in combination with 8-thio-CAMP analogs than
when incubated with 8-amino derivatives. Only a limited
degree of synergism was expressed when either C-6 analog
was incubated in combination with the 8-aminohexylaminoor 8-aminobutylamino-CAMP(average synergism quotient =
1.2). Similar results were achieved with these C-6 analogs in
combination with 8-aminobenzyl-CAMP(not shown).
These data for lipolytic effects are in excellent agreement
with studies using the same analogs on activation of isolated
adipocyte type I1 protein kinase (Fig. 5B). The basal protein
kinase activity ratio, determined in the absence of added cyclic
nucleotides, varied between 0.08 and 0.13. In each experiment,
the basal activity ratio was subtracted to give the change in
activity ratio due to the analogs being tested. The order of
effectiveness of the analog pairs forsynergism of protein
kinase activation follows the same order of effectiveness for
glycerol release. Both N'-benzoyl-cAMP and N'-carbamoyl-
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DISCUSSION

The activation of protein kinase by cAMP is a critical step
in the process of hormone-stimulated cascade amplification.
Koshland et al. (23) have defined two forms of signal amplification. Magnitude amplification is characterized by the production of a large number of output molecules (e.g. free fatty
acids released from adipose tissue) generated by a small
number of stimulus molecules (e.g. hormone). Sensitivity amplification, on the other hand, is characterized by a greater
percentage change in response than expected from the percentage change in stimulus. Studies presented here support
other work(12-15) and provide proof that protein kinase
activation is an important step in sensitivity amplification.
Briefly, it has been established that thepositive cooperativity
in cyclic nucleotide binding is reflected by cooperativity in

protein kinase activation (15). In the present studies, the
synergistic activation of protein kinase is well correlated with
a synergistic lipolytic response when isolated protein kinase
or adipocytes are incubated in the presence of a combination
of a Site 1-selective and a Site2-selective cAMP analog.
Data presented here not only demonstrate that theprotein
kinase is the mediator of the cyclic nucleotide analog synergistic effect on lipolysis, but also suggest that itis the type I1
isozyme which is responsible for the lipolytic effect.For both
protein kinase activation and lipolysis, the synergism was
greater when a C-6 analog was incubated in combination with
a C-&thio analog than when incubated with a C-&amino
analog, a type I1 protein kinase response (15). Furthermore,
the pattern of selectivesynergism of lipolysis wasclosely
correlated with the same pattern of synergism of type I1
protein kinase activation.
The efficacy of analogs as protein kinase agonists in intact
cells or in intact organisms is dependent upon the concentration of analog at its site of action. The lipolytic efficacyof all
the analogs tested appears to be explained by consideration
of at least two of three basic analog properties: high lipophilicity, low K,, for protein kinase activation, and stability to low
K , phosphodiesterase hydrolysis. For example, some of the
most effective lipolytic agents generally have relatively high
KOvalues for protein kinase activation, but have favorable
partition coefficients and are relatively resistant to thephosphodiesterase. On the other hand, relatively ineffective lipolytic agents have lower K,,values but tend tohave unfavorable
partition coefficients and are less resistant to thephosphodiesterase. Analogs which have either excessively high or low
partition coefficients are not so effective lipolytic agents as
might be expected fromtheir K , values. This could be dueto
their inability to cross the cell membrane in thecase of a low
partition coefficient or the inability to partition out of the
membrane or the lipid droplet in the case of a high partition
coefficient. Although these conclusions seem sound, we have
not presently ruled out that some analogs may be metabolized
by a mechanism other than the phosphodiesterase(s) to a
more effective ora less effective lipolyticagent.
The strong correlation between synergism of lipolysis and
synergism of protein kinase activation, in addition to the
synergism of binding (14, 15) and type I1 protein kinase
activaton previously demonstrated (15), leaves little doubt
that protein kinase, and not any other mechanism, is reponsible forthe synergistic effect of analogs on lipolysis. However,
a discussion of other possible mechanisms is presented. The
presently available data argue against phosphodiesterase. The
analog specificity of the high K , phosphodiesterase has not
been studied but the effects of cAMP analogs on the low K ,
phosphodiesterase, which is believed to play a major role in
the hydrolysis of intracellualr cAMP (19, 24), havebeen
investigated. It is difficult to explain the synergism based on
analog effects on this enzyme.Although the synergism of
lipolysis and protein kinase activation occur overa wide range
of concentrations, this synergism is readily seen at low analog
concentrations, almost certainly below concentrations required for phosphodiesterase inhibition. In addition, since the
best lipolytic agents, N6-carbamoylpropyl- and N'-benzoylCAMP,have IWvalues 492 and 45 times higher than their KO
values, it seems highly unlikely that the phosphodiesterase
would significantly contribute to the analog-stimulated lipolysis. Someof the datapresented here also argueagainst a role
for the adenosine receptor in the synergism of lipolysis. Fain
and Malbon (25) have demonstrated that adipose tissue is
normally under tonic adenosine inhibition, causing adenylate
cyclase and lipolysis to be less responsive to hormone stimu-
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propyl-CAMP acted most synergisticallywith 8-thioisopropyland 8-thiomethyl-CAMP. The C-6 analogs weremuch less
effective in combination with 8-aminohexylamino- and 8aminobutylamino-CAMP. Although the increases in activity
ratio due to the individual analogs alone were small, the
magnitude of change due to the8-thio derivatives were greater
than that due to the 8-amino derivatives. However, other
studies on activation of adipocyte protein kinase indicated
that increasing the effect on activity ratio by increasing the
concentration of 8-amino derivatives or decreasing the effect
by decreasing the concentrations of 8-thio derivatives had no
bearing on their order of effectiveness for synergism when
incubated in combination with C-6 analogs. These studies
also indicated that synergism of adipocyte protein kinase
couldbereadily demonstrated as long as the sum of the
individual analog effects on the activity ratio did not exceed
about 50% of the maximal activity ratio change. This is in
agreement with previous studies on the synergism of activation of rat hearttype I and bovine heart type I1 protein kinase
(15).
It had previously been shown that 8-thio-CAMPwas considerably better in combination with C-6 analogs for binding
to andactivation of type I1 than for type I protein kinase (14,
15). However, in results not shown, 8-thio-CAMP was relatively poor when tested for lipolysis with these C-6 analogs
although 8-thio-CAMP acted more synergistically with N6carbamoylpropyl-than with N'-benzoyl-cAMP. The inability
of 8-thio-CAMP to show strong synergism in combination
with (2-6 analogs in the isolated adipocyte system or in the
adipocyte protein kinase activation studies is not totally
understood but may suggestdifferences in the type I1 kinases
from heart and adipose tissue. Differences in these enzymes
have already been suggested (9).
Other studies comparing synergism of glycerol release and
synergism of protein kinase activation were also carried out
using N6-butyryl-, N6-carbamoylpropyl-, and N6-benzoylcAMP in combination with the Site 1-selective analog 8aminomethyl-CAMP and the Site 2-selective analog 8-thiobenzyl-CAMP. The combination of 8-aminomethyl-CAMP
with each of the C-6 analogs did not produce synergism of
lipolysis. However, 8-thiobenzyl-CAMPproduced synergism
quotients between 3.2 and 3.6 when incubated in combination
with C-6 analogs. These data were consistent with the experiments carried out measuring protein kinase activity ratios.
In each case, the synergism produced with the C-6 analog in
combination with 8-thiobenzyl-CAMP was
1.5-1.7
times
greater than when C-6 analogs were paired with 8-aminomethyl-CAMP.Again, the overall correlation of lipolysis and
protein kinase activation in these experiments is unmistakable.
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lation. The experiments here were carried out at relatively
high adipocyte concentrations where adenosine inhibition of
adenylate cyclase was essentially complete. This conclusion
was supported since analog-stimulated lipolysis was not inhibited by N6-phenylisopropyladenosine;therefore, under
these conditions, endogenous cAMP formation was minimal
and the likelihood of endogenously generated cAMP due to
an adenosine receptor mechanism was remote. It is possible,
however, that if the adenylate cyclase inhibition were released
by some adenosine antagonist which could be generated or
introduced as a contaminant of the analog preparation the
endogenous cAMP levels couldincrease. This does not appear
to be the mechanism of the synergism of lipolysis sinceIBMX,
an adenosine receptor antagonist (26), does not prevent the
lipolytic synergism due to N6-benzoyl- and 8-bromo-CAMP
(data notshown).
There are several possible explanations for the concaveupward dose-response effects of analogs on lipolysis.One
possibility is that low concentrations of the analog activate
one protein kinase isozyme and higher concentrations activate
the other type. This seems unlikely in view of the fact that
type I is very low, or absent, in the adipocyte. It has not been
totally ruled out that high concentrations of these analogs
inhibit either the phosphodiesterase or the adenosine receptor
and endogenous cAMP contributes to the concave-upward
dose-response curves.
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Two classes of cAMP analogs which are selective for the two different
cAMP-binding sites of type II protein kinase demonstrate synergism when added
together to intact adipocytes.
S J Beebe, R Holloway, S R Rannels and J D Corbin
J. Biol. Chem. 1984, 259:3539-3547.
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